Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic considerations in diseases of cardiac ion channels.

The Journal of pharmacology and experimental therapeutics - 1 Dec 2003

Anantharam Arun, Markowitz Steven M, Abbott Geoffrey W

Abstract excerpt

Phenotypic variation within a species arises from differences in genetic makeup between individuals. This inherent diversity empowers the species as a whole to explore and expand into new environmental niches and also to survive new stressors within an ever-changing environment. Paradoxically, one class of stressors currently challenging the human population is therapeutic drugs: medications designed to combat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arrhythmias, Cardiac
Share to Deafness
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Ion Channels

Share to Long QT Syndrome

Share to Myocardium

Share to Pharmacogenetics

Source

Identifiers

PMID: 14561846
DOI: 10.1124/jpet.103.054569

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic considerations in diseases of cardiac ion channels.PMID 14561846Read ↗

Pharmacogenetics and cardiac ion channels.Semantic proximity Read ↗

Pathophysiology of ion channel mutations.Semantic proximity Read ↗

Pharmacogenetics and drug-induced arrhythmiasSemantic proximity Read ↗

Susceptibility genes and modifiers for cardiac arrhythmias.Semantic proximity Read ↗

Cardiac sodium channels and inherited electrophysiologic disorders: a pharmacogenetic overview.Semantic proximity Read ↗

KCNE genetics and pharmacogenomics in cardiac arrhythmias: much ado about nothing?Semantic proximity Read ↗

A genetic framework for improving arrhythmia therapy.Semantic proximity Read ↗

Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.Semantic proximity Read ↗

The primary arrhythmia syndromes: same mutation, different manifestations. Are we starting to understand why?Semantic proximity Read ↗

The genetics of pro-arrhythmic adverse drug reactions.Semantic proximity Read ↗

Arrhythmia pharmacogenomics: methodological considerations.Semantic proximity Read ↗

[Pharmacogenetic aspects of antiarrhythmic drug therapy].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.